Fotemustine Compared With Dacarbazine in Patients ...

Fotemustine compared with dacarbazine in patients with ... - PubMed

ORR was higher in the fotemustine arm compared to the DTIC arm in first-line treatment of disseminated melanoma. A trend in favor of fotemustine in terms of ...

Fotemustine Compared With Dacarbazine in Patients With ...

Fotemustine was shown to be effective as single agent against MM with an overall response rate of 24% in a large phase II trial including 153 assessable ...

Fotemustine plus dacarbazine for malignant melanoma - PubMed

119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15-18. After a 5-week rest, ...

Phase III randomized study of fotemustine and dacarbazine versus ...

Patients and procedures ... This multicenter, randomized, open-label, 2×2 factorial phase III trial (ClinicalTrials.gov NCT01359956) compared ...

(PDF) Fotemustine Compared With Dacarbazine in Patients With ...

059). Median survival was 7.3 months with fotemustine versus 5.6 months with DTIC (P=.067). The main toxicity was grade 3 to 4 neutropenia (51 ...

Fotemustine plus dacarbazine for malignant melanoma

119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15–18. After a 5-week rest, fotemustine ...

Fotemustine Compared With Dacarbazine in Patients With ... - Scite

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study · Abstract: ORR was higher in the fotemustine arm ...

Fotemustine Compared With Dacarbazine in Patients ... - Altmetric

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study · Journal of Clinical Oncology, March 2004 · 10.1200/jco ...

Ipilimumab with fotemustine in metastatic melanoma - The Lancet

Avril, MF ∙ Aamdal, S ∙ Grob, JJ ∙ et al. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J ...

Fotemustine Compared With Dacarbazine in Patients With ... - OUCI

Purpose To compare fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, ...

Fotemustine and dacarbazine plus recombinant interferon alpha2a ...

References (15) · Fotemustine plus dacarbazine for malignant melanoma · Eur J Cancer · Sequential administration of dacarbazine and fotemustine in patients with ...

Combination chemotherapy of dacarbazine and fotemustine in ...

A total of 70 patients presenting with a disseminated malignant melanoma were entered into a multicentric study of combination chemotherapy using ...

Survival with dacarbazine and fotemustine in newly diagnosed ...

A total of 55 patients with histologically proven glioblastoma multiforme (total gross resection: n=24, subtotal resection: n=20, ...

Phase III randomized study of fotemustine and dacarbazine versus ...

Menu Y: Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol 2004,. 22 ...

Final results of a randomised phase III study (EORTC 18032)

In patients with measurable disease, overall response rate was higher in the temozolomide arm than in the dacarbazine arm (14.5% versus 9.8%, respectively), but ...

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients ...

Sixty-four consecutive patients with advanced melanoma were treated with a combination of fotemustine 100 mg/m2 intravenously (i.v.) on Day ...

Hepatic intra-arterial versus intravenous fotemustine in patients with ...

HIA treatment with fotemustine did not translate into an improved OS compared with IV treatment, despite better RR and PFS. Intrahepatic treatment should still ...

Ipilimumab and fotemustine in patients with advanced melanoma ...

14. Avril, MF ∙ Aamdal, S ∙ Grob, JJ ∙ et al. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin ...

Cisplatin, dacarbazine, and fotemustine plus interferon Î± in patients ...

long term survival compared with a previous series of patients who were treated by the authors. However, considering the currently available ...

M. F. Avril, et al., “Fotemustine Compared with Dacarbazine in ...

M. F. Avril, et al., “Fotemustine Compared with Dacarbazine in Patients with disseminated malignant melanoma A Phase III Study,” Journal of Clinical ...